Candel Therapeutics (CADL) Institutional Ownership $5.49 -0.37 (-6.31%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Candel Therapeutics (NASDAQ:CADL)CurrentInstitutional OwnershipPercentage13.93%Number ofInstitutional Buyers(last 12 months)50TotalInstitutional Inflows(last 12 months)$79.71MNumber ofInstitutional Sellers(last 12 months)10TotalInstitutional Outflows(last 12 months)$4.64M Get CADL Insider Trade Alerts Want to know when executives and insiders are buying or selling Candel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CADL Institutional Buying and Selling by Quarter Candel Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 9,608$49K0.0%+361.7%0.019% 8/15/2025 Bridgeway Capital Management LLC55,100$279K0.0%N/A0.110% 8/15/2025 Bank of America Corp DE73,123$370K0.0%-59.2%0.146% 8/15/2025 Acorn Capital Advisors LLC2,580,517$13.06M8.5%+19.9%5.151% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.21,520$109K0.0%+28.5%0.043% 8/14/2025 The Manufacturers Life Insurance Company 13,826$70K0.0%N/A0.028% 8/13/2025 Marshall Wace LLP161,480$817K0.0%-31.2%0.322% 8/12/2025 XTX Topco Ltd74,629$378K0.0%N/A0.149% 8/12/2025 Rhumbline Advisers54,498$276K0.0%+63.6%0.109% 8/12/2025 JPMorgan Chase & Co.19,533$99K0.0%+36.9%0.039% Get the Latest News and Ratings for CADL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Candel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/8/2025 Intech Investment Management LLC23,871$121K0.0%-16.4%0.048% 8/8/2025 Geode Capital Management LLC903,970$4.58M0.0%+31.5%1.804% 8/7/2025 Los Angeles Capital Management LLC24,810$126K0.0%N/A0.050% 7/18/2025 Tanager Wealth Management LLP196,631$995K0.1%N/A0.392% 7/17/2025 Janney Montgomery Scott LLC27,290$138K0.0%+29.4%0.054% 7/11/2025 Halter Ferguson Financial Inc.776,516$3.93M1.4%+12.0%1.550% 6/27/2025 Goldman Sachs Group Inc.54,666$309K0.0%-16.2%0.109% 5/29/2025 Rhumbline Advisers33,302$188K0.0%+26.8%0.066% 5/19/2025 Acorn Capital Advisors LLC2,152,252$12.16M7.9%+11.0%4.368% 5/16/2025 Goldman Sachs Group Inc.54,666$309K0.0%-16.2%0.111% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.16,748$95K0.0%+37.7%0.034% 5/15/2025 Baker BROS. Advisors LP2,437,189$13.77M0.2%-18.3%4.947% 5/14/2025 Corebridge Financial Inc.13,933$79K0.0%+29.4%0.028% 5/14/2025 AlphaQuest LLC10,870$61K0.0%N/A0.022% 5/14/2025 EntryPoint Capital LLC17,907$101K0.0%N/A0.036% 5/12/2025 Nuveen LLC78,145$442K0.0%N/A0.159% 5/12/2025 Invesco Ltd.10,413$59K0.0%N/A0.021% 5/12/2025 Taylor Financial Group Inc.10,000$56K0.0%N/A0.020% 5/9/2025 Deutsche Bank AG26,211$148K0.0%-16.8%0.053% 5/9/2025 Charles Schwab Investment Management Inc.83,880$474K0.0%+60.7%0.170% 5/9/2025 Halter Ferguson Financial Inc.693,153$3.92M2.0%+1.7%1.407% 5/7/2025 HB Wealth Management LLC94,300$533K0.0%+8.0%0.191% 5/5/2025 Private Advisor Group LLC10,350$58K0.0%N/A0.022% 4/30/2025 Stratos Wealth Advisors LLC23,000$130K0.0%N/A0.049% 4/29/2025 Bank of New York Mellon Corp60,759$343K0.0%+35.1%0.129% 4/17/2025 Janney Montgomery Scott LLC21,090$119K0.0%+104.3%0.045% 4/8/2025 Rhumbline Advisers33,302$188K0.0%+26.8%0.071% 2/17/2025 Squarepoint Ops LLC19,311$168K0.0%+86.6%0.059% 2/17/2025Nuveen Asset Management LLC68,226$592K0.0%+3.0%0.210% 2/17/2025 Maven Securities LTD51,731$449K0.0%N/A0.159% What's the Best Way to Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today.2/17/2025 Millennium Management LLC31,626$275K0.0%+130.6%0.097% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.12,165$106K0.0%+12.4%0.037% 2/17/2025 Deutsche Bank AG31,522$274K0.0%+5,814.1%0.097% 2/17/2025 Bridgeway Capital Management LLC77,195$670K0.0%-4.2%0.238% 2/17/2025 Braidwell LP1,600,000$13.89M0.4%N/A4.926% 2/17/2025 Baker BROS. Advisors LP2,981,983$25.88M0.3%N/A9.181% 2/17/2025 Bank of America Corp DE66,811$580K0.0%+205.6%0.206% 2/17/2025 BNP Paribas Financial Markets3,434$30K0.0%N/A0.011% 2/17/2025 Acorn Capital Advisors LLC1,939,644$16.84M9.2%N/A5.972% 2/14/2025 Northern Trust Corp165,021$1.43M0.0%+3.9%0.508% 2/14/2025 Oxford Asset Management LLP12,003$104K0.1%N/A0.037% 2/14/2025 Birchview Capital LP60,000$521K0.4%N/A0.185% 2/14/2025 Heights Capital Management Inc.30,000$260K0.1%N/A0.092% 2/14/2025 MetLife Investment Management LLC13,773$120K0.0%+9.7%0.042% 2/13/2025 Portolan Capital Management LLC753,745$6.54M0.4%N/A2.321% 2/13/2025 Barclays PLC34,317$297K0.0%+19.6%0.106% 2/13/2025 Russell Investments Group Ltd.3,753$33K0.0%+75.1%0.012% 2/13/2025 Wells Fargo & Company MN10,122$88K0.0%+63.6%0.031% 2/12/2025 Geode Capital Management LLC455,424$3.95M0.0%+1.4%1.402% 2/12/2025 JPMorgan Chase & Co.10,426$90K0.0%+15.2%0.032% 2/11/2025 LPL Financial LLC10,703$93K0.0%N/A0.033% 2/11/2025 Halter Ferguson Financial Inc.681,334$5.91M2.4%+123.7%2.098% 2/10/2025 Commonwealth Equity Services LLC41,098$357K0.0%N/A0.127% 2/6/2025 Charles Schwab Investment Management Inc.52,190$453K0.0%+11.6%0.161% 2/5/2025 Oppenheimer & Co. Inc.37,915$329K0.0%N/A0.117% 1/30/2025 Rhumbline Advisers26,272$228K0.0%+17.0%0.081% 1/30/2025 Vontobel Holding Ltd.19,000$165K0.0%-13.6%0.058% 1/15/2025 HB Wealth Management LLC87,300$696K0.0%+54.1%0.269% 12/26/2024 JPMorgan Chase & Co.9,051$63K0.0%-53.2%0.028% 11/19/2024 Barclays PLC28,688$199K0.0%+327.1%0.088% 11/16/2024 Geode Capital Management LLC448,997$3.11M0.0%+12.8%1.399% 11/15/2024 Barclays PLC28,688$199K0.0%+327.1%0.089% 11/15/2024 MML Investors Services LLC22,313$155K0.0%-69.6%0.070% 11/15/2024 State Street Corp492,005$3.41M0.0%+4.1%1.534% 11/15/2024 Atom Investors LP14,873$103K0.0%N/A0.046% 11/14/2024 MetLife Investment Management LLC12,558$87K0.0%N/A0.039% 11/13/2024 FMR LLC6,573$46K0.0%N/A0.020% 9/16/2024 Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 9/16/2024 Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024 Cubist Systematic Strategies LLC26,121$162K0.0%N/A0.088% 8/14/2024 Point72 DIFC Ltd4,927$31K0.0%N/A0.017% 8/13/2024 Sands Capital Ventures LLC405,837$2.52M0.8%-50.0%1.364% 8/9/2024 Renaissance Technologies LLC20,600$128K0.0%-63.8%0.069% 8/1/2024 Rhumbline Advisers22,985$143K0.0%N/A0.077% 7/26/2024 Bank of New York Mellon Corp54,449$338K0.0%N/A0.183% 1/29/2024Baystate Wealth Management LLC76,910$113K0.0%-21.0%0.266% 5/10/2023 Resources Investment Advisors LLC.25,428$34K0.0%N/A0.088% 4/25/2023Baystate Wealth Management LLC105,854$143K0.0%N/A0.366% 11/14/2022 Point72 Asset Management L.P.403,131$1.27M0.0%-45.7%1.395% 5/6/2022 Empirical Asset Management LLC12,000$61K0.1%N/A0.042% What's the Best Way to Lower RMD Taxes? (Ad)Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain retirement accounts. Without the right strategy, these withdrawals can significantly increase your tax bill and shrink your nest egg. SmartAsset outlines six strategies that could help reduce your RMDs and potentially lower your tax burden. Their free tool can match you with vetted fiduciary financial advisors in your area—professionals legally bound to act in your best interest.Click here to see the six strategies and get your free advisor matches today.4/26/2022 Kestra Advisory Services LLC12,500$64K0.0%N/A0.044% 2/15/2022Northpond Ventures LLC1,935,215$15.13M5.3%N/A6.745% 2/15/2022 683 Capital Management LLC40,929$320K0.0%N/A0.143% 11/15/2021Caas Capital Management LP50,000$542K0.0%N/A0.174% 11/15/2021 Franklin Resources Inc.1,125,000$12.20M0.0%N/A3.921% 11/9/2021BlackRock Inc.22,326$242K0.0%N/A0.078% (Data available from 1/1/2016 forward) CADL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CADL shares? During the previous two years, 58 institutional investors and hedge funds held shares of Candel Therapeutics. The most heavily invested institutionals were Braidwell LP ($13.89M), Baker BROS. Advisors LP ($13.77M), Acorn Capital Advisors LLC ($13.06M), Portolan Capital Management LLC ($6.54M), Geode Capital Management LLC ($4.58M), Halter Ferguson Financial Inc. ($3.93M), and State Street Corp ($3.41M).Learn more on Candel Therapeutics' institutional investors. What percentage of Candel Therapeutics' stock is owned by institutional investors? 13.93% of Candel Therapeutics' stock is owned by institutional investors. Learn more on CADL's institutional investor holdings. Which institutional investors have been buying Candel Therapeutics' stock? Of the 50 institutional investors that purchased Candel Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Baker BROS. Advisors LP ($2.98M), Acorn Capital Advisors LLC ($2.58M), Braidwell LP ($1.60M), Portolan Capital Management LLC ($753.75K), Halter Ferguson Financial Inc. ($471.98K), Geode Capital Management LLC ($274.05K), and Tanager Wealth Management LLP ($196.63K). How much institutional buying is happening at Candel Therapeutics? Institutional investors have bought a total of 9,861,092 shares in the last 24 months. This purchase volume represents approximately $79.71M in transactions. Which of Candel Therapeutics' major shareholders have been selling company stock? Of the 10 institutional investors that sold Candel Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Baker BROS. Advisors LP ($544.79K), Bank of America Corp DE ($106.13K), Marshall Wace LLP ($73.12K), MML Investors Services LLC ($51.06K), Goldman Sachs Group Inc. ($21.14K), JPMorgan Chase & Co. ($10.31K), and Deutsche Bank AG ($5.31K). How much institutional selling is happening at Candel Therapeutics? Institutional investors have sold a total of 822,955 shares in the last 24 months. This volume of shares sold represents approximately $4.64M in transactions. Related Companies XERS Institutional Ownership ABCL Institutional Ownership EVO Institutional Ownership COLL Institutional Ownership NTLA Institutional Ownership CVAC Institutional Ownership ELVN Institutional Ownership CALT Institutional Ownership SPRY Institutional Ownership PHVS Institutional Ownership This page (NASDAQ:CADL) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Candel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Candel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
